EXPLAINED: What to expect from zoetis next quarterly earnings report | Vintage Vibes

Valued at a market cap of $55.2 billion, Zoetis Inc. (ZTS) discovers, develops, manufactures, and commercializes animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products. The Parsippany, New Jersey-based company is scheduled to announce its fiscal Q4 earnings for 2025 before the market opens on Thursday, Feb. 12. 

Before this event, analysts expect this animal healthcare company to report a profit of $1.40 per share, in line with the year-ago quarter. The company has topped Wall Street’s earnings estimates in each of the last four quarters. In Q3, its EPS of $1.70 surpassed the consensus estimates by 4.9%.